HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of hepatocellular carcinoma (HCC) in a patient 17 years after recovery from chronic hepatitis B and seroconversion to anti-HBs.

Abstract
A 63-year-old man was admitted to hospital in 2003 for treatment of a hepatocellular carcinoma (HCC). He was negative for HBs antigen (HBsAg) and anti-HCV antibody, and positive for anti-HBs. He had a past history of chronic hepatitis B. In 1986, HBsAg had become negative with the development of anti-HBs. In 2003, an HCC was detected and liver resection was carried out. Histological examination revealed moderately differentiated HCC and slightly fibrotic liver. It is suggested that a diagnosis of HCC, combined with negativity for HBsAg and anti-HCV antibody, may include cases of past recovery from chronic hepatitis B, such as this case.
AuthorsShuichiro Shigematsu, Teru Kumagi, Yoichi Hiasa, Tomorou Yoshida, Masashi Hirooka, Yoshio Tokumoto, Bunzo Matsuura, Kojiro Michitaka, Norio Horiike, Taiji Tohyama, Morikazu Onji
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 46 Issue 1 Pg. 29-33 ( 2007) ISSN: 1349-7235 [Electronic] Japan
PMID17202730 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Antibodies, Viral (immunology)
  • Carcinoma, Hepatocellular (diagnosis, etiology, immunology)
  • Disease Susceptibility
  • Hepatitis B (immunology)
  • Hepatitis B virus (immunology)
  • Humans
  • Liver (pathology)
  • Liver Neoplasms (diagnosis, etiology, immunology)
  • Male
  • Middle Aged
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: